[LONDON, UK, 12th December 2024] Specialist Biometrics CRO, Veramed, today announced the appointment of Diana Wong as Chief Operating Officer. Diana’s arrival comes at a time of significant expansion for Veramed as the company looks to establish itself as the CRO of choice globally.
Diana Wong brings a wealth of experience in strategy and business operations within clinical research organizations to her new role as COO of Veramed. With over 20 years of expertise in the healthcare and life sciences sectors, Diana has successfully led clinical research teams across North America, Europe, the Middle East, and Asia, giving her a truly global perspective.
Having previously served as the Head of Real-World Insights for IQVIA’s Nordic division, Diana’s proven track record includes sustainably scaling the business during her tenure. Her strategic vision and operational excellence will be invaluable in ensuring Veramed delivers exceptional, high-quality services to its clients while enhancing scalability and operational efficiency.
”I’m excited to join Veramed at this key moment in its growth. With its strong reputation for quality and innovation, Veramed is poised to make an even greater impact in clinical research. I look forward to working with the team to enhance operations, scale capabilities, and deliver exceptional value to clients globally.
Diana WongChief Operating Officer, Veramed
”We are delighted to welcome Diana Wong as our new Chief Operating Officer. Veramed continues to excel in delivering exceptional biometrics services worldwide, and Diana’s appointment underscores the company’s commitment to driving innovation and meeting the evolving needs of the biopharmaceutical industry.
Matt JonesCo-Founder and Chief Executive Officer, Veramed
In her role as COO, Diana Wong will play a pivotal role in steering Veramed towards achieving its growth objectives, maintaining its reputation for excellence, and fostering a collaborative and client-focused approach within the organization.
About Veramed
Veramed is a high-performing partner that provides a comprehensive suite of biostatistical and data management consulting services to a global client base. Their team is dedicated to accelerating evidence generation and advancing patient health by integrating people, innovation, and technology. They were awarded “Best Contract Research Organization – Specialist Providers” at the 18th Annual Scrip Awards in 2022 and certified as a B Corp™ for the first time in 2020.
Veramed is passionate about making a difference in patient communities around the world. Being uniquely practitioner-led, the company challenges how advanced biometrics services can be used to help move the needle on the speed, quality, and effectiveness of pharma and biotech pipeline delivery.
